Guardian Capital (Pennsylvania)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303K Sell
2,360
-783
-25% -$91.6K 0.25% 60
2026
Q1
$378K Sell
3,143
-1,653
-34% -$191K 0.36% 57
2025
Q4
$505K Buy
+4,796
New +$450K 0.45% 57

Other funds holding MRK

Guardian Capital (Pennsylvania)'s MRK Position: Q2 2026 in Review

Guardian Capital (Pennsylvania) reduced its Merck (MRK) stake by 25% in Q2 2026, selling an estimated $91.6K and leaving 2,360 shares worth $303K. The position accounts for 0.25% of the portfolio, ranked #60.

Guardian Capital (Pennsylvania) first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $505K in Q4 2025. 3,828 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Guardian Capital (Pennsylvania) held 2,360 shares of Merck worth $303K as of Q2 2026.
  • Guardian Capital (Pennsylvania) sold 783 Merck shares in Q2 2026, an estimated $91.6K.
  • Merck made up 0.25% of Guardian Capital (Pennsylvania)'s portfolio in Q2 2026, its #60 holding.
  • Guardian Capital (Pennsylvania) first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Guardian Capital (Pennsylvania)'s Merck position peaked at $505K in Q4 2025.
  • 3,828 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Guardian Capital (Pennsylvania)'s 13F filing for Q2 2026, filed 7 Aug 2026.